Skip to Content

CyberKnife: Important Tool in the Fight Against Prostate Cancer

 

cyber knife

Luther Brady, M.D., Philadelphia
CyberKnife medical director;
Rachelle Lanciano, M.D.; and John
Lamond, M.D., with the CyberKnife
machine.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In Brief

  • Crozer-Keystone Health System, through its affiliation with Philadelphia CyberKnife in Havertown (a service of Delaware County Memorial Hospital), is able to offer CyberKnife treatment for prostate cancer patients.
  • CyberKnife uses highly concentrated and incredibly precise beams of radiation to treat benign and malignant tumors, blood vessel malformations and many functional disorders without damaging the surrounding healthy tissue.
  • Located on West Chester Pike in Havertown, and operated by US Radiosurgery, Philadelphia CyberKnife is the most experienced facility in the Delaware Valley with the CyberKnife system.

September is National Prostate Cancer Awareness Month. Prostate cancer is the most common cancer among men in the United States after non-melanoma skin cancer, and is the third-leading cause of cancer-related deaths. According to the American Cancer Society, prostate cancer is expected to be diagnosed in 241,740 men in 2012.

Crozer-Keystone Health System, through its affiliation with Philadelphia CyberKnife in Havertown (a service of Delaware County Memorial Hospital), is able to offer CyberKnife treatment for prostate cancer patients. Harry Pursel knows firsthand the benefits that state-of-the-art robotic radiosurgery can bring.

“CyberKnife was the best experience I’ve had with any medical treatment,” says Pursel, a resident of Phillipsburg, New Jersey. “After my last of the five treatments I had to undergo, I drove home thinking that I hadn’t even had anything done to me. I felt fine and experienced no side effects whatsoever. I even went to work after my hour commute home. I have been cancer-free for over a year now.”

CyberKnife uses highly concentrated and incredibly precise beams of radiation to treat benign and malignant tumors, blood vessel malformations and many functional disorders without damaging the surrounding healthy tissue. “This is particularly important for prostate cancer cases because curative doses are delivered the prostate while sparing the rectum and bladder—which are both located extremely close to the prostate,” says Rachelle Lanciano, M.D., chair of Radiation Oncology at Delaware County Memorial Hospital (DCMH). “Believe it or not, the prostate moves. CyberKnife is the only technology that tracks the prostate during treatment and makes adjustments in order to be sure the high doses of radiation are delivered accurately throughout the entire treatment.”

“Factors like disease stage, age, lifestyle and simple personal preference play the most important role in selecting whether or not a patient is a candidate for CyberKnife®,” says John Lamond, M.D., radiation oncologist at Crozer-Chester Medical Center and associate medical director of Philadelphia CyberKnife. “We always undergo a detailed medical examination with each patient to determine if they are a candidate.”

If the patient is a candidate, treatment is completed within one to two weeks (five separate treatments). The CyberKnife machine is made up of a lightweight linear accelerator that is mounted on a robotic arm. Using image guidance cameras, the system locates the tumor to continuously track, detect and correct for tumor and patient movements throughout the treatment, ensuring accuracy and efficiency. Multiple radiation beams enter the body from different targeting positions and angles. All the beams painlessly intersect within the tumor where the cumulative dose is high enough to destroy the cancer cells.

In addition to CyberKnife, Crozer-Keystone offers other radiation therapy choices to treat prostate cancer — including intensity modulated radiation therapy (IMRT) and internal radiation seed implants (brachytherapy). “One of the great things about our health system is that we are able to specifically customize our treatments to a patient’s diagnosis and needs,” Lamond says.

Pursel, who was treated by Lanciano, says that the entire staff, from the doctors and nurses to the office personnel, were very caring. “From the first time I stepped foot into the Philadelphia CyberKnife office, right up until my very last visit, I couldn’t have been treated any better,” he adds.

Located on West Chester Pike in Havertown, and operated by US Radiosurgery, Philadelphia CyberKnife is the most experienced facility in the Delaware Valley with the CyberKnife system. For more information, visit www.phillycyberknife.com or call (610) 446-6850.

For more information about Crozer-Keystone’s cancer services, call 1-866-695-HOPE (1-866-695-4673), or visit http://ckcancer.crozerkeystone.org.

Contact Us

Crozer-Keystone Health System

Grant Gegwich, Vice President

Phone: 610-447-6316
Fax: 610-447-2015
Pager: 610-604-1728

Crozer-Chester Medical Center

Grant Gegwich, Vice President

Phone: 610-447-6316
Fax: 610-447-2015
Pager: 610-604-1728

Kate Stier, Director

Phone: 610-447-6314
Fax: 610-447-2015
Pager: 610-541-3130

Community Hospital

Grant Gegwich, Vice President

Phone: 610-447-6316
Fax: 610-447-2015
Pager: 610-604-1728

Kate Stier,  Director

Phone: 610-447-6314
Fax: 610-447-2015
Pager: 610-541-3130

Springfield Hospital

Grant Gegwich, Vice President

Phone: 610-447-6316
Fax: 610-447-2015
Pager: 610-604-1728

Kate Stier,  Director

Phone: 610-447-6314
Fax: 610-447-2015
Pager: 610-541-3130

Healthplex Sports Club

Grant Gegwich, Vice President

Phone: 610-447-6316
Fax: 610-447-2015
Pager: 610-604-1728

Kate Stier, Director

Phone: 610-447-6314
Fax: 610-447-2015
Pager: 610-541-3130

Delaware County Memorial Hospital

Mary Wascavage
Director of Public Relations and Marketing

Phone: 610-284-8619
Fax: 610-284-8606
Pager: 610-318-0861

Taylor Hospital

Mary Wascavage, Director

Phone: 610-284-8619
Fax: 610-284-8606
Pager: 610-318-0861